Arbutus Biopharma Corp, Inc. (NASDAQ:ABUS) Q1 2022 Earnings Conference Call May 5, 2022 8:45 AM ET Company Participants Lisa Caperelli - VP, IR William Collier - President, CEO & Director Michael Sofia - Chief Scientific Officer David Hastings - CFO & CAO Gaston Picchio - Chief Development Officer Conference Call Participants Douglas Buchanan - JMP Securities Yuchen Ding - Jefferies Thomas Yip - H.C. Wainwright & Co. Luke Herrmann - Robert W. Baird & Co. Keay Nakae - Chardan Capital Markets Operator Good da ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2021 Earnings Conference Call March 3, 2022 8:45 AM ET Company Participants Lisa Caperelli - Vice President, Investor Relations William Collier - President and Chief Executive Officer David Hastings - Chief Financial Officer Gaston Picchio - Chief Development Officer Michael Sofia - Chief Scientific Officer Conference Call Participants Roy Buchanan - JMP Securities Dennis Ding - Jefferies Ed Arce - H.C. Wainwright Brian Skorney - Baird Operator Good day and th ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2021 Earnings Conference Call November 4, 2021 8:45 AM ET Company Participants Lisa Caperelli - Vice President or Investor Relations Bill Collier - President and Chief Executive Officer Dave Hastings - Chief Financial Officer Gaston Picchio - Chief Development Officer Mike Sofia - Chief Scientific Officer Conference Call Participants Roy Buchanan - JMP Securities Luke Herrmann - Baird Ed Arce - H.C. Wainwright & Company Keay Nakae - Chardan Kelechi Chikere - Je ...

| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-----------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Corporate | | | NASDAQ: ABUS www.arbutusbio.com Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, amon ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2021 Earnings Conference Call August 5, 2021 8:15 AM ET Company Participants Pam Murphy - IR Bill Collier - President, CEO Dave Hastings - CFO Gaston Picchio - CDO Mike Sofia - CSO Conference Call Participants Roy Buchanan - JMP Securities Keay Nakae - Chardan Kelechi Chikere - Jefferies Operator Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation 2021 Second Quarter Financial Results and Corporate Update Conference Call. At th ...